Novel potent sigma(1) ligands: N-[omega-(tetralin-1-yl)alkyl]piperidine derivatives

被引:9
作者
Berardi, F
Giudice, G
Perrone, R
Tortorella, V
Govoni, S
Lucchi, L
机构
[1] UNIV PAVIA,IST FARMACOL,I-27100 PAVIA,ITALY
[2] UNIV MILAN,IST SCI FARMACOL,I-20133 MILAN,ITALY
关键词
D O I
10.1021/jm9508898
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of substituted N-[(tetralin-1-yl)alkyl]piperidines and a number of related N-di-n-propyl[(tetralin-1-yl)alkyl]amines were prepared. Structural modifications such as piperidine substitutions, intermediate chain lengthening, and the nature of the aromatic ring were explored in order to identify structural requirements for selective al affinity. They were tested in radioligand binding assays on al, 5-HT1A and 5-HT2 serotonergic, PCP (phencyclidine), and D-2 dopaminergic receptors. Almost all the compounds reported here showed a high to superpotent sigma(1) affinity, and some compounds also demonstrated a widespread selectivity over the other receptors. In [H-3]-(+)-pentazocine binding, 3,3-dimethyl-1-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-n-propyl]piperidine (24) and 3,3-dimethyl-1-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)-n-butyl]piperidine (26) reached the lowest K-i values (0.4 and 0.8 nM, respectively); compound 24 also demonstrated a considerable PCP affinity (K-i 34.2 nM), whereas compound 26 was suitably selective. Furthermore the presence of a 4-benzyl substituent on the piperidine ring (compound 16, K-i = 3.9 nM on sigma(1) sites) caused an increase in 5-HT1A affinity (K-i < 0.14 nM).
引用
收藏
页码:4255 / 4260
页数:6
相关论文
共 41 条
[1]  
Ablordeppey S.Y., 1992, MED CHEM RES, V2, P368
[2]  
ABOUGHARBIA M, 1993, ANNU REP MED CHEM, V28, P1
[3]   New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives [J].
Berardi, F ;
Colabufo, NA ;
Giudice, G ;
Perrone, R ;
Tortorella, V ;
Govoni, S ;
Lucchi, L .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) :176-182
[4]  
BOUCHARD P, 1993, J NEUROSCI, V13, P3926
[5]   2 BINDING-SITES FOR H-3-SPIROPERIDOL ON RAT STRIATAL MEMBRANES [J].
BRILEY, M ;
LANGER, SZ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 50 (03) :283-284
[6]   [H-3] (+)-PENTAZOCINE BINDING TO RAT-BRAIN SIGMA(1) RECEPTORS [J].
CAGNOTTO, A ;
BASTONE, A ;
MENNINI, T .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 266 (02) :131-138
[7]   ENANTIOMERIC N-SUBSTITUTED N-NORMETAZOCINES - A COMPARATIVE-STUDY OF AFFINITIES AT SIGMA, PCP, AND MU OPIOID RECEPTORS [J].
CARROLL, FI ;
ABRAHAM, P ;
PARHAM, K ;
BAI, X ;
ZHANG, X ;
BRINE, GA ;
MASCARELLA, SW ;
MARTIN, BR ;
MAY, EL ;
SAUSS, C ;
DIPAOLO, L ;
WALLACE, P ;
WALKER, JM ;
BOWEN, WD .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (15) :2812-2818
[8]   SPIROPIPERIDINES AS HIGH-AFFINITY, SELECTIVE SIGMA-LIGANDS [J].
CHAMBERS, MS ;
BAKER, R ;
BILLINGTON, DC ;
KNIGHT, AK ;
MIDDLEMISS, DN ;
WONG, EHF .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (11) :2033-2039
[9]  
DEBONNEL G, 1993, J PSYCHIATR NEUROSCI, V18, P157
[10]   A NEW APPROACH TO THE DESIGN OF SIGMA-2-SELECTIVE LIGANDS - SYNTHESIS AND EVALUATION OF N-[2-(3,4-DICHLOROPHENYL)ETHYL]-N-METHYL-2(1-PYRROLIDINYL)ETHYLAMINE-RELATED POLYAMINES AT SIGMA-1 AND SIGMA-2 RECEPTOR SUBTYPES [J].
DECOSTA, BR ;
HE, XS ;
DOMINGUEZ, C ;
CUTTS, J ;
WILLIAMS, W ;
BOWEN, WD .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (02) :314-321